Vergleich

Anti-Mouse CD279 (PD-1) [Clone 29F.1A12] — Purified (PhenoCyler-Fusion (CODEX)® Ready) - 50 µg

ArtNr LEIN-P501-50ug
Hersteller Leinco Technologies
Menge 50 ug
Kategorie
Typ Antibody Monoclonal
Applikationen IHC
Clon 29F.1A12
Specific against other
ECLASS 10.1 42030590
ECLASS 11.0 42030590
UNSPSC 12352203
Versandbedingung Gekühlt
Lieferbar
Manufacturer - Applications
IHC FF, PhenoCycler®
Manufacturer - Category
Primary Monoclonal Antibodies>Immune Checkpoints|PhenoCycler®>PhenoCycler® Validated Antibodies|Primary Monoclonal Antibodies>Surfacetag Mouse CD Markers|Primary Monoclonal Antibodies>Tumor Markers
Manufacturer - Targets
PD-1
Shipping Temperature
Next Day 2 - 8°C
Storage Conditions
This antibody is stable for at least one week when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Product Description
PD-1 is a 50-55 kD member of the B7 Ig superfamily. PD-1 is also a member of the extended CD28/CTLA-4 family of T cell regulators and is suspected to play a role in lymphocyte clonal selection and peripheral tolerance. The ligands of PD-1 are PD-L1 and PD-L2, and are also members of the B7 Ig superfamily. PD-1 and its ligands negatively regulate immune responses. PD-L1, or B7-Homolog 1, is a 40 kD type I transmembrane protein that has been reported to costimulate T cell growth and cytokine production. The interaction of PD-1 with its ligand PD-L1 is critical in the inhibition of T cell responses that include T cell proliferation and cytokine production. PD-L1 has increased expression in several cancers. Inhibition of the interaction between PD-1 and PD-L1 can serve as an immune checkpoint blockade by improving T-cell responses In vitro and mediating preclinical antitumor activity. Within the field of checkpoint inhibition, combination therapy using anti-PD1 in conjunction with anti-CTLA4 has significant therapeutic potential for tumor treatments. PD-L2 is a 25 kD type I transmembrane ligand of PD-1. Via PD-1, PD-L2 can serve as a coinhibitor of T cell functions. Regulation of T cell responses, including enhanced T cell proliferation and cytokine production, can result from mAbs that block the PD-L2 and PD-1 interaction.
Manufacturer - Research Area
Cancer, Immunology, Inhibitory Molecules
Concentration
0.5 mg/ml
Formulation
This purified antibody is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4.
Antigen Distribution
PD-1 is expressed on a subset of CD4-CD8- thymocytes, and on activated T and B cells.
Protein
PD-1
Keywords
Monoclonal Antibody, PD-1, Programmed Death-1, CD279, PD 1, RMP1-14, Mouse PD-1 Functional Grade, PD1, Programmed Death-1, CD279 antigen, CD279, hPD-1, PD1, PD1hPD-l, PDCD1, programmed cell death 1, programmed cell death protein 1, Protein PD-1, SLEB2, CD279, programmed cell death 1 protein, Programmed cell death protein 1, Protein PD-1, systemic lupus erythematosus susceptibility 2, CD279, hPD-1, hPD-l, hSLE1, Mouse PD-1, Mouse PD1, PDCD1, SLEB2

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 50 ug
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen